Café

© 2026 Longbridge｜Terms of Service Privacy Policy

HCM

HCM

12.6400.64%( +0.080 )

LongbridgeAI

HUTCHMED shares are trading higher after the company announced high-level results from the SAFFRON Phase III trial.

benzinga_article

Aug 17, 2026 at 07:35 AM

HUTCHMED shares are trading higher after the company announced high-level results from the SAFFRON Phase III trial.

Source: benzinga_article The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Related Stocks

Hutchmed China

USHCM

+0.64%

HUTCHMED

HK00013

-4.75%